NO920222L - Fremgangsmaate for fremstilling av kinolin-, pyridin- og imidazolderivater, samt forskjellige slike derivater - Google Patents
Fremgangsmaate for fremstilling av kinolin-, pyridin- og imidazolderivater, samt forskjellige slike derivaterInfo
- Publication number
- NO920222L NO920222L NO92920222A NO920222A NO920222L NO 920222 L NO920222 L NO 920222L NO 92920222 A NO92920222 A NO 92920222A NO 920222 A NO920222 A NO 920222A NO 920222 L NO920222 L NO 920222L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- quinoline
- pyridine
- procedure
- preparation
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101026A GB9101026D0 (en) | 1991-01-17 | 1991-01-17 | Chemical process |
| GB919106876A GB9106876D0 (en) | 1991-04-02 | 1991-04-02 | Manufacturing process |
| GB919121726A GB9121726D0 (en) | 1991-10-14 | 1991-10-14 | Process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920222D0 NO920222D0 (no) | 1992-01-16 |
| NO920222L true NO920222L (no) | 1992-07-20 |
Family
ID=27265456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920222A NO920222L (no) | 1991-01-17 | 1992-01-16 | Fremgangsmaate for fremstilling av kinolin-, pyridin- og imidazolderivater, samt forskjellige slike derivater |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5294716A (cs) |
| EP (1) | EP0495626A1 (cs) |
| JP (1) | JPH0559042A (cs) |
| KR (1) | KR920014800A (cs) |
| AU (1) | AU9012091A (cs) |
| CA (1) | CA2058899A1 (cs) |
| CS (1) | CS9992A3 (cs) |
| FI (1) | FI920212A7 (cs) |
| GB (1) | GB9200758D0 (cs) |
| HU (1) | HUT60262A (cs) |
| IE (1) | IE914572A1 (cs) |
| IL (1) | IL100580A0 (cs) |
| NO (1) | NO920222L (cs) |
| PT (1) | PT100022A (cs) |
| ZW (1) | ZW792A1 (cs) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE914572A1 (en) * | 1991-01-17 | 1992-07-29 | Zeneca Ltd | Chemical process |
| US5602127A (en) * | 1991-02-06 | 1997-02-11 | Karl Thomae Gmbh | (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists |
| US5594003A (en) * | 1991-02-06 | 1997-01-14 | Dr. Karl Thomae Gmbh | Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists |
| US5591762A (en) * | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| US5252753A (en) * | 1991-11-01 | 1993-10-12 | Ortho Pharmaceutical Corporation | Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| EP1384717B1 (en) * | 1991-11-18 | 2008-05-14 | E.I. Dupont De Nemours And Company | 2-(2'-triphenylmethyl-2'H-tetrazol-5'-yl)phenylboronic acid intermediates for the synthesis of A II receptor antagonists |
| GB9201715D0 (en) * | 1992-01-28 | 1992-03-11 | Ici Plc | Chemical process |
| RU2109736C1 (ru) * | 1992-12-17 | 1998-04-27 | Санкио Компани Лимитед | Производные бифенила и способ их получения |
| WO2003030937A1 (en) * | 2001-10-05 | 2003-04-17 | Ono Pharmaceutical Co., Ltd. | Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| WO2003093262A2 (en) * | 2002-04-29 | 2003-11-13 | Teva Pharmaceutical Industries Ltd. | Processes for preparing losartan and losartan potassium |
| US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
| JP4511550B2 (ja) * | 2004-09-02 | 2010-07-28 | テバ ファーマシューティカル インダストリーズ リミティド | オルメサルタンメドキソミルの調製法 |
| KR20090102883A (ko) * | 2004-09-02 | 2009-09-30 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
| US20060258727A1 (en) * | 2005-01-03 | 2006-11-16 | Lilach Hedvati | Olmesartan medoxomil with reduced levels of impurities |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2828764A1 (en) * | 2011-03-03 | 2012-09-07 | Treventis Corporation | Anti-amyloid compounds and methods |
| CN104487427B (zh) * | 2012-06-25 | 2017-03-15 | 萨尼奥纳有限责任公司 | 四唑衍生物和它们作为钾通道调节剂的用途 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
| WO2020140001A1 (en) * | 2018-12-28 | 2020-07-02 | Riboscience Llc | Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors |
| ES2960987T3 (es) | 2019-04-12 | 2024-03-07 | Riboscience Llc | Derivados de heteroarilo bicíclicos como inhibidores de la ectonucleótido pirofosfatasa fosfodiesterasa 1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
| EP0412848B1 (en) * | 1989-08-11 | 1995-01-18 | Zeneca Limited | Quinoline derivatives, process for their preparation and their use as medicaments |
| GB2244054B (en) * | 1990-04-19 | 1994-04-06 | Ici Plc | Pyridine derivatives |
| IE914572A1 (en) * | 1991-01-17 | 1992-07-29 | Zeneca Ltd | Chemical process |
| US5252753A (en) * | 1991-11-01 | 1993-10-12 | Ortho Pharmaceutical Corporation | Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
-
1991
- 1991-12-30 IE IE457291A patent/IE914572A1/en not_active Application Discontinuation
- 1991-12-31 AU AU90120/91A patent/AU9012091A/en not_active Abandoned
-
1992
- 1992-01-03 IL IL100580A patent/IL100580A0/xx unknown
- 1992-01-07 CA CA002058899A patent/CA2058899A1/en not_active Abandoned
- 1992-01-13 ZW ZW7/92A patent/ZW792A1/xx unknown
- 1992-01-14 CS CS9299A patent/CS9992A3/cs unknown
- 1992-01-14 GB GB929200758A patent/GB9200758D0/en active Pending
- 1992-01-14 EP EP92300307A patent/EP0495626A1/en not_active Withdrawn
- 1992-01-15 HU HU929200130A patent/HUT60262A/hu unknown
- 1992-01-16 KR KR1019920000687A patent/KR920014800A/ko not_active Withdrawn
- 1992-01-16 PT PT100022A patent/PT100022A/pt not_active Application Discontinuation
- 1992-01-16 NO NO92920222A patent/NO920222L/no unknown
- 1992-01-17 FI FI920212A patent/FI920212A7/fi not_active Application Discontinuation
- 1992-01-17 JP JP4006874A patent/JPH0559042A/ja active Pending
- 1992-01-17 US US07/822,395 patent/US5294716A/en not_active Expired - Fee Related
-
1994
- 1994-01-31 US US08/189,954 patent/US5420292A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2058899A1 (en) | 1992-07-18 |
| FI920212A0 (fi) | 1992-01-17 |
| GB9200758D0 (en) | 1992-03-11 |
| NO920222D0 (no) | 1992-01-16 |
| HU9200130D0 (en) | 1992-04-28 |
| EP0495626A1 (en) | 1992-07-22 |
| IE914572A1 (en) | 1992-07-29 |
| ZW792A1 (en) | 1992-09-30 |
| US5420292A (en) | 1995-05-30 |
| AU9012091A (en) | 1992-07-23 |
| US5294716A (en) | 1994-03-15 |
| HUT60262A (en) | 1992-08-28 |
| IL100580A0 (en) | 1992-09-06 |
| KR920014800A (ko) | 1992-08-25 |
| CS9992A3 (en) | 1992-08-12 |
| PT100022A (pt) | 1993-02-26 |
| FI920212A7 (fi) | 1992-07-18 |
| JPH0559042A (ja) | 1993-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO920222L (no) | Fremgangsmaate for fremstilling av kinolin-, pyridin- og imidazolderivater, samt forskjellige slike derivater | |
| NO883722D0 (no) | Fremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater. | |
| NO913234D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
| NO932176D0 (no) | Kinolin-, naftyridin- og pyridobenzoksazinderivater | |
| NO904987L (no) | Fremgangsmaate for fremstilling av indolderivater. | |
| NO862650L (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
| NO892936L (no) | Fremgangsmaate for fremstilling av furanderivater. | |
| NO903431D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO903275L (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO905377L (no) | Fremgangsmaate for fremstilling av glycerolderivater. | |
| NO903043D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
| NO924990D0 (no) | Substituerte pyridin-n-oksyder, fremgangsmaater for fremstilling av dem, samt anvendelser av dem | |
| NO891588L (no) | Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater. | |
| NO903207D0 (no) | Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater. | |
| BR9205939A (pt) | Derivados de 4-aril-3-(heteroalilureído)quinolina | |
| NO891985L (no) | Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater. | |
| NO904805D0 (no) | Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater. | |
| NO902762D0 (no) | Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater. | |
| NO920636L (no) | Fremgangsmaate for fremstilling av 9-amino-1,2,3,4-tetra-hydroakridin | |
| NO911672L (no) | Fremgangsmaate for fremstilling av alkansulfonanilid-derivater. | |
| NO911382L (no) | Fremgangsmaate for fremstilling av pyridin- og kinolin-derivater. | |
| NO905047D0 (no) | Fremgangsmaate for fremstilling av selenofenderivater. | |
| NO921389L (no) | Fremgangsmaate for fremstilling av kinolinderivater | |
| NO931700D0 (no) | N-halogenchitosaner, fremgangsmaate for fremstilling samt anvendelse av slike | |
| NO920168D0 (no) | Absorpsjonsmiddel, fremgangsmaate for fremstilling av absorpsjonsmiddel samt anvendelse av dette |